Literature DB >> 10676974

Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students.

H Richardson1, E Franco, J Pintos, J Bergeron, M Arella, P Tellier.   

Abstract

BACKGROUND: Previous studies have been inconsistent about the degree of sexual transmissibility of cervical human papillomavirus (HPV) infection. The authors hypothesize that risk factors for HPV infection vary according to HPV type. GOAL: To estimate the prevalence of HPV infection in asymptomatic women and to identify risk factors for overall HPV infection and HPV infection by oncogenic and nononcogenic type. STUDY
DESIGN: A cross-sectional survey was conducted at the McGill University clinic in Montreal. Cervical specimens were collected from 489 female students presenting at the clinic for a routine Papanicolaou test. Data on potential risk factors was obtained by questionnaire. Human papillomavirus DNA was detected by the polymerase chain reaction using consensus primers (MY09/11) followed by hybridization with generic and type-specific probes using Southern blot and dot blot techniques.
RESULTS: The overall HPV prevalence was 21.8%. A low-risk HPV infection was found in 6.2% of the women, 11.8% had a high-risk HPV infection (types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58), 7.1% had an unknown HPV type, and 2.7% had a multiple type infection. Two profiles emerged for sexual activity and risk of HPV infection according to oncogenic risk after multivariate analysis. Lifetime frequency of sexual intercourse and lifetime number of oral sex partners was associated with high-oncogenic-risk HPV infections; however, HPV infection with low-oncogenic-risk types was invariant with respect to markers of sexual activity.
CONCLUSION: These results suggest that there are differences in epidemiologic correlates of transmission between low-risk and high-oncogenic-risk HPV types based on oncogenicity. This finding has important implications for primary prevention of HPV infection and cervical cancer precursors.

Entities:  

Mesh:

Year:  2000        PMID: 10676974     DOI: 10.1097/00007435-200002000-00005

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

1.  Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic.

Authors:  E I Svare; S K Kjaer; A M Worm; A Osterlind; C J L M Meijer; A J C van den Brule
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

2.  Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.

Authors:  Sharon A Nachman; Miriam Chernoff; Philimon Gona; Russell B Van Dyke; Wayne M Dankner; George R Seage; James Oleske; Paige L Williams
Journal:  Arch Pediatr Adolesc Med       Date:  2009-02

3.  Reproductive health of adolescent girls perinatally infected with HIV.

Authors:  Susan B Brogly; D Heather Watts; Nathalie Ylitalo; Eduardo L Franco; George R Seage; James Oleske; Michelle Eagle; Russell Van Dyke
Journal:  Am J Public Health       Date:  2007-04-26       Impact factor: 9.308

4.  There is a high prevalence of human papillomavirus infection in American Indian women of the Northern Plains.

Authors:  Maria C Bell; Delf Schmidt-Grimminger; Sarah Patrick; Tim Ryschon; Laurie Linz; Subhash C Chauhan
Journal:  Gynecol Oncol       Date:  2007-07-30       Impact factor: 5.482

Review 5.  Canadian oncogenic human papillomavirus cervical infection prevalence: systematic review and meta-analysis.

Authors:  Andrea C Tricco; Carmen H Ng; Vladimir Gilca; Andrea Anonychuk; Ba' Pham; Shirra Berliner
Journal:  BMC Infect Dis       Date:  2011-09-05       Impact factor: 3.090

6.  Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey.

Authors:  Quamrun Nahar; Farhana Sultana; Anadil Alam; Jessica Yasmine Islam; Mustafizur Rahman; Fatema Khatun; Nazmul Alam; Sushil Kanta Dasgupta; Lena Marions; Mohammed Kamal; Alejandro Cravioto; Laura Reichenbach
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

7.  High molecular prevalence of HPV and other sexually transmitted infections in a population of asymptomatic women who work or study at a Brazilian university.

Authors:  Tamy Taianne Suehiro; Fabrícia Gimenes; Raquel Pantarotto Souza; Sergio Ken Iti Taura; Rita Cristina Cardoso Cestari; Mary Mayumi Taguti Irie; Cinthia Gandolfi Boer; Marcia Edilaine Lopes Consolaro; Vânia Ramos Sela da Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-01-20       Impact factor: 1.846

8.  Type-specific human papillomavirus infections and Pap test findings in Inuit and non-Inuit women in Nunavut, Canada.

Authors:  S Totten; A Severini; G C Jayaraman; S T Faybush; G Johnson; A A Demers; I Sobol; Y Mao; T Wong
Journal:  Can Commun Dis Rep       Date:  2015-03-05

Review 9.  Human papillomavirus infection and use of oral contraceptives.

Authors:  J Green; A Berrington de Gonzalez; J S Smith; S Franceschi; P Appleby; M Plummer; V Beral
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

10.  Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.

Authors:  Agnihotram V Ramanakumar; Paulo Naud; Cecilia M Roteli-Martins; Newton S de Carvalho; Paola C de Borba; Julio C Teixeira; Mark Blatter; Anna-Barbara Moscicki; Diane M Harper; Barbara Romanowski; Stephen K Tyring; Brian Ramjattan; Anne Schuind; Gary Dubin; Eduardo L Franco
Journal:  BMJ Open       Date:  2016-08-26       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.